Pituitary

Article	Citations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	93
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	44
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	37
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	34
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	30
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	29
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	27
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	26
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	26
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	26
Pituitary: hic manebimus optime	24
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	24
Genetic models of Cushing’s disease	23
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	21
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	21
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	20
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	20
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	20
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	19
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	19
Machine learning as a clinical decision support tool for patients with acromegaly	19
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	19
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	19
Pituitary metastases: a case series and scoping review	18
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	18

Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	18
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	17
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	17
Diagnosis of growth hormone deficiency: searching for Consensus along life	16
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	16
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	15
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	15
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	15
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	15
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	15
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	15
TSH-secreting pituitary adenomas and bone	15
IGF-1 is positively associated with BMI in patients with acromegaly	14
Cushing’s disease and bone	14
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	13
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	13
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	13
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	13
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	13
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	12
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	12
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	12
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	12
Acromegaly is associated with a distinct oral and gut microbiota	12
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	12
Is diabetes with acromegaly for life?	11
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	11
Copeptin after pituitary surgery: is it worth measuring?	11
Pituitary surgery and COVID	11
Long COVID and pituitary dysfunctions: a bidirectional relationship?	11
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	10
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	10
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	10
Refractory nonfunctioning pituitary adenomas	10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	10
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	10
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	10
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	10
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	10
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	10
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	10
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	10
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	10
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	9
Cushing’s disease: role of preoperative and primary medical therapy	9

High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	9
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	9
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	9
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	9
An update on, and genetics of refractory adenomas of childhood	9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	9
Skeletal fragility in pituitary disease: how can we predict fracture risk?	9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	9
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	9
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	8
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	8
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	8
How to manage intolerance to dopamine agonist in patients with prolactinoma	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
Correction: consensus on criteria for acromegaly diagnosis and remission	8
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	8
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	8
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	8
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	8
Cushing’s syndrome: Guidance on thromboprophylaxis at last	8
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	8
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre	7
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	7
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	7
Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism	7
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	7
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	7
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	7
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	7
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	7
Pituitary acting drugs: cabergoline and pasireotide	7
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma	6
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center	6
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center	6
Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity	6
Vitamin D in pituitary driven osteopathies	6
Posterior pituitary tumors: an entity unto itself	6
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	6
Cushing’s syndrome and COVID-19	6
Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications	6
Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent manners	6
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	6
Letter to the editor regarding “Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature”	6
Elevated risk of recurrence and retreatment for silent pituitary adenomas	6
Metastases to the pituitary gland: insights from the German pituitary tumor registry	6
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	6
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus	6
Cushing’s disease in children: unique features and update on genetics	6
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	6
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis	5
Changing the name of diabetes insipidus	5
Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas	5
Role of Radiation in the treatment of Cushing Disease	5
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay	5
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	5
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	5
GHR disruption in mature adult mice alters xenobiotic metabolism gene expression in the liver	5
Novel imaging techniques in refractory pituitary adenomas	5
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas	5
Sheehan syndrome: a current approach to a dormant disease	4
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	4
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	4
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	4
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	4
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	4
Precocious puberty, pandemic and beyond	4
Opioids and pituitary function: expert opinion	4
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	4
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	4
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	4
Response to letter to the editor “proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors”	4
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	4
Morphometric study of the pituitary gland and stalk with emphasis on lifestyle factors	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	4
Letter to the editor: Pituitary hyperplasia causing visual symptoms in a young woman planning pregnancy	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	4

A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	4
Cushing’s disease: adrenal steroidogenesis inhibitors	4
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	4
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	4
Hypopituitarism and COVID-19	4
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	4
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	4
Kidney function in acromegaly: evidence from a long-term observational study	4
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	3
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	3
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	3
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review	3
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	3
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	3
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	3
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	3
Epigenetic implications in the pathogenesis of corticotroph tumors	3
Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there?	3
Enhancing diagnostic tools for vasopressin deficiency: insights from a single-center cohort study	3
FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours	3
A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system	3
Predictive factors for post-therapeutic biochemical discordance in acromegaly: a monocentric analysis of 156 cases	3
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society	3
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	3
Impact of insurance on outcomes of patients undergoing endoscopic transsphenoidal surgery for non-functional pituitary adenomas: a single institution study	3
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)	3
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	3
Impact of nasal septal deviation on surgical outcomes in endoscopic transsphenoidal surgery: a population-based study	3
Correlates of prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenomas: varying definitions and non-clinical factors	3
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing’s disease: safety, feasibility, and success	3
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	3
Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases	2
Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series	2
Delayed postoperative hyponatremia in patients with acromegaly: incidence and predictive factors	2
Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis	2
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview	2
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events	2
Colonoscopy in acromegaly: when and why	2
Typing of inflammatory lesions of the pituitary	2
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers	2
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)	2
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas	2
Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study	2
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	2
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	2
Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts	2
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study	2
Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis	2
Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency	2
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation	2
Pituitary apoplexy score, toward standardized decision-making: a descriptive study	2
Newer parameters of the octreotide test in patients with acromegaly	2
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas	2
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis	2
Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas	2
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery	2
Lateral orientation of Rathke cleft cysts may be associated with high rates of recurrence after surgery	2
Advances in surgical approaches for refractory pituitary adenomas	2
Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery	2
Frailty and pituitary surgery: a systematic review	2
Treatment of acromegaly-induced diabetes: an updated proposal	2
Cushing’s disease: role of bilateral adrenalectomy	2
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study	2
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	2
Surgical outcomes and quality of life in Rathke’s cleft cysts undergoing endoscopic transsphenoidal resection: a multicentre study and systematic review of the literature	2
Pituitary and COVID-19 vaccination: a systematic review	2
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients	2